Drug Type Cytokines |
Synonyms |
Target |
Mechanism IL-2Rβγ agonists(Interleukin-2 Rβγ agonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | US | 05 Jun 2024 | |
Locally Advanced Malignant Solid Neoplasm | IND Approval | CN | 29 Oct 2024 | |
Metastatic Solid Tumor | IND Approval | CN | 29 Oct 2024 |